Crossingbridge Advisors, LLC has filed its 13F form on August 13, 2024 for Q2 2024 where it was disclosed a total value porftolio of $169 Billion distributed in 57 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Blackline Inc 0.125 8/1/2024 with a value of $31.6B, Jazz Investments I LTD 1.5 8/15/2024 with a value of $25.5B, Biomarin Pharmaceutical 0.599 8/1/2024 with a value of $16.1B, Chegg Inc 0.125 3/15/2025 with a value of $11.6B, and Cartesian Growth Corp Ii with a value of $6B.

Examining the 13F form we can see an increase of $37B in the current position value, from $132B to 169B.

Crossingbridge Advisors, LLC is based out at Pleasantville, NY

Below you can find more details about Crossingbridge Advisors, LLC portfolio as well as his latest detailed transactions.

Portfolio value $169 Billion
Financial Services: $11.6 Billion
Real Estate: $5.81 Billion
Communication Services: $372 Million
Technology: $267 Million
ETFs: $259 Million
Healthcare: $2.72 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 57
  • Current Value $169 Billion
  • Prior Value $132 Billion
  • Filing
  • Period Q2 2024
  • Filing Date August 13, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 15 stocks
  • Additional Purchases 9 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 10 stocks
Track This Portfolio

Track Crossingbridge Advisors, LLC Portfolio

Follow Crossingbridge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossingbridge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crossingbridge Advisors, LLC with notifications on news.